CN1429073A - 使用α－MSH及其衍生物的基因治疗系统和方法 - Google Patents

使用α－MSH及其衍生物的基因治疗系统和方法 Download PDF

Info

Publication number
CN1429073A
CN1429073A CN01808571A CN01808571A CN1429073A CN 1429073 A CN1429073 A CN 1429073A CN 01808571 A CN01808571 A CN 01808571A CN 01808571 A CN01808571 A CN 01808571A CN 1429073 A CN1429073 A CN 1429073A
Authority
CN
China
Prior art keywords
msh
gene therapy
gene
derivative
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01808571A
Other languages
English (en)
Chinese (zh)
Inventor
詹姆斯·M·利普顿
安娜·P·卡塔尼亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zengen Inc
Original Assignee
Zengen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zengen Inc filed Critical Zengen Inc
Publication of CN1429073A publication Critical patent/CN1429073A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN01808571A 2000-04-28 2001-04-27 使用α－MSH及其衍生物的基因治疗系统和方法 Pending CN1429073A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20028700P 2000-04-28 2000-04-28
US60/200,287 2000-04-28

Publications (1)

Publication Number Publication Date
CN1429073A true CN1429073A (zh) 2003-07-09

Family

ID=22741073

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01808571A Pending CN1429073A (zh) 2000-04-28 2001-04-27 使用α－MSH及其衍生物的基因治疗系统和方法

Country Status (6)

Country Link
EP (1) EP1280409A4 (ja)
JP (1) JP2004509065A (ja)
CN (1) CN1429073A (ja)
AU (1) AU2001257420A1 (ja)
CA (1) CA2406755A1 (ja)
WO (1) WO2001082699A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106905432A (zh) * 2015-12-18 2017-06-30 兰州大学 一种α促黑素细胞激素的融合蛋白及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532347A (en) * 1992-04-10 1996-07-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization DNA encoding α melanocyte stimulating hormone receptor
US5744304A (en) * 1995-05-30 1998-04-28 Board Of Regents, The University Of Texas System Inflammation-induced expression of a recombinant gene
ATE550429T1 (de) * 1996-11-20 2012-04-15 Crucell Holland Bv Adenovirus-zusammensetzungen erhältlich durch ein verbessertes produktions- und reinigungsverfahren
WO2000033658A1 (en) * 1998-12-09 2000-06-15 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
JP2002534968A (ja) * 1999-01-22 2002-10-22 ザ スキーペンズ アイ リサーチ インスティテュート インコーポレイテッド α−メラニン細胞刺激ホルモンによる調節Ｔ細胞の活性化
CA2415938A1 (en) * 2000-07-14 2002-01-24 Zycos Inc. Alpha-msh related compounds and methods of use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106905432A (zh) * 2015-12-18 2017-06-30 兰州大学 一种α促黑素细胞激素的融合蛋白及其制备方法和应用
CN106905432B (zh) * 2015-12-18 2018-12-21 兰州大学 一种α促黑素细胞激素的融合蛋白及其制备方法和应用

Also Published As

Publication number Publication date
WO2001082699A1 (en) 2001-11-08
JP2004509065A (ja) 2004-03-25
EP1280409A1 (en) 2003-02-05
CA2406755A1 (en) 2001-11-08
EP1280409A4 (en) 2004-05-19
AU2001257420A1 (en) 2001-11-12

Similar Documents

Publication Publication Date Title
RU2171261C2 (ru) Липофильные производные пептидных гормонов
TWI541020B (zh) 生物活性胜肽
CN107530454B (zh) 二聚胶原杂交肽和使用方法
CA2412279A1 (en) "pseudo"-native chemical ligation
JPH0720993B2 (ja) 生長因子
JP2018536405A5 (ja)
JP7213811B2 (ja) 新規なステープルペプチドおよびその使用
US6429188B1 (en) Method for treating the endotoxic shock in mammals
CA3075670A1 (en) Pharmaceutical constructs with enhanced binding affinity with albumin
CN1429073A (zh) 使用α－MSH及其衍生物的基因治疗系统和方法
RU2503684C2 (ru) Иммуномодулирующие олигопептиды
KR20200140291A (ko) 치료제의 제어된 방출을 위한 조성물
CN113039194A (zh) 具有免疫调节特性的肽
US20040110696A1 (en) Gene therapy system and method using alpha-msh and its derivatives
Uehara et al. The dipeptide Lys-Pro attenuates interleukin-1β-induced anorexia
AU2005238173B2 (en) Biologically active peptide vapeehptllteaplnpk derivatives
US5440022A (en) Hepatokine and methods for its use
CA2462713C (en) Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
US20030108523A1 (en) Cancer treatment system
KR20080016675A (ko) 세포 핵-엔터링 조성물
JPH09502175A (ja) 免疫およびｃｎｓ療法に有用な新規トリペプチド
EP0796276B1 (en) Gradual modification, super-agonists and antagonists of signal-proteins and peptides
CN103897031A (zh) 化学修饰的胸腺五肽及其合成方法
JPH01287097A (ja) 抗腫瘍性蛋白質
WO1993006128A1 (en) Tnf antagonist peptides

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication